Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Failure, Chronic | 7 | 2021 | 923 | 1.650 |
Why?
|
| Kidney Transplantation | 10 | 2021 | 560 | 1.630 |
Why?
|
| Renal Dialysis | 8 | 2015 | 932 | 1.170 |
Why?
|
| Catheters, Indwelling | 4 | 2012 | 150 | 0.820 |
Why?
|
| Waiting Lists | 1 | 2021 | 236 | 0.600 |
Why?
|
| Perioperative Care | 1 | 2021 | 211 | 0.580 |
Why?
|
| Health Policy | 1 | 2021 | 221 | 0.580 |
Why?
|
| Graft Survival | 2 | 2018 | 454 | 0.560 |
Why?
|
| Tissue and Organ Procurement | 1 | 2021 | 240 | 0.550 |
Why?
|
| Bacteremia | 3 | 2012 | 420 | 0.530 |
Why?
|
| Biofilms | 3 | 2012 | 93 | 0.510 |
Why?
|
| Cause of Death | 1 | 2018 | 484 | 0.500 |
Why?
|
| Acute Kidney Injury | 4 | 2021 | 664 | 0.450 |
Why?
|
| Kidney | 2 | 2015 | 1283 | 0.430 |
Why?
|
| Time-to-Treatment | 1 | 2015 | 200 | 0.410 |
Why?
|
| Glomerular Filtration Rate | 2 | 2018 | 538 | 0.400 |
Why?
|
| Brain Edema | 1 | 2013 | 63 | 0.390 |
Why?
|
| Cerebral Angiography | 1 | 2013 | 103 | 0.380 |
Why?
|
| Equipment Contamination | 3 | 2007 | 40 | 0.380 |
Why?
|
| Medicare | 1 | 2015 | 424 | 0.360 |
Why?
|
| Aneurysm, False | 1 | 2013 | 84 | 0.360 |
Why?
|
| Carotid Artery Diseases | 1 | 2013 | 133 | 0.360 |
Why?
|
| Catheterization | 3 | 2008 | 235 | 0.360 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2015 | 692 | 0.350 |
Why?
|
| Diabetic Nephropathies | 2 | 2018 | 113 | 0.350 |
Why?
|
| Anti-Bacterial Agents | 4 | 2012 | 2503 | 0.340 |
Why?
|
| Catheter-Related Infections | 1 | 2012 | 137 | 0.340 |
Why?
|
| Prosthesis-Related Infections | 1 | 2012 | 183 | 0.320 |
Why?
|
| Contrast Media | 1 | 2013 | 459 | 0.310 |
Why?
|
| Bacterial Infections | 1 | 2012 | 309 | 0.310 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 750 | 0.300 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2007 | 148 | 0.290 |
Why?
|
| Hip Fractures | 2 | 2017 | 67 | 0.240 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 2036 | 0.240 |
Why?
|
| Pyelonephritis | 1 | 2006 | 29 | 0.240 |
Why?
|
| Pancreas Transplantation | 2 | 2005 | 30 | 0.240 |
Why?
|
| Ceftriaxone | 1 | 2006 | 68 | 0.240 |
Why?
|
| Middle Aged | 18 | 2018 | 27672 | 0.240 |
Why?
|
| Emphysema | 1 | 2006 | 62 | 0.230 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2005 | 9 | 0.230 |
Why?
|
| Lipectomy | 1 | 2005 | 9 | 0.230 |
Why?
|
| Nephrotic Syndrome | 1 | 2005 | 50 | 0.230 |
Why?
|
| Proteinuria | 1 | 2005 | 105 | 0.220 |
Why?
|
| Endocarditis, Bacterial | 1 | 2006 | 132 | 0.220 |
Why?
|
| Diabetic Angiopathies | 1 | 2005 | 66 | 0.220 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2004 | 9 | 0.220 |
Why?
|
| Castleman Disease | 1 | 2004 | 15 | 0.220 |
Why?
|
| Health Care Costs | 1 | 2007 | 392 | 0.200 |
Why?
|
| HIV Seropositivity | 1 | 2004 | 123 | 0.200 |
Why?
|
| Male | 21 | 2021 | 62490 | 0.200 |
Why?
|
| Preoperative Care | 1 | 2005 | 354 | 0.190 |
Why?
|
| Multiple Myeloma | 1 | 2005 | 207 | 0.190 |
Why?
|
| Cryptococcus neoformans | 1 | 2002 | 21 | 0.190 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2006 | 370 | 0.180 |
Why?
|
| Cryptococcosis | 1 | 2002 | 40 | 0.180 |
Why?
|
| Humans | 26 | 2021 | 126679 | 0.170 |
Why?
|
| Pleural Effusion | 1 | 2002 | 106 | 0.170 |
Why?
|
| Health Care Rationing | 1 | 2021 | 59 | 0.170 |
Why?
|
| Europe | 1 | 2021 | 358 | 0.160 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 158 | 0.160 |
Why?
|
| United States | 6 | 2021 | 11297 | 0.160 |
Why?
|
| Adult | 12 | 2018 | 30379 | 0.160 |
Why?
|
| Mass Screening | 1 | 2005 | 802 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2018 | 798 | 0.150 |
Why?
|
| Organ Transplantation | 1 | 2021 | 174 | 0.150 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 849 | 0.140 |
Why?
|
| Aged | 7 | 2018 | 20321 | 0.140 |
Why?
|
| Intensive Care Units | 1 | 2021 | 495 | 0.140 |
Why?
|
| Abatacept | 1 | 2017 | 24 | 0.140 |
Why?
|
| Minocycline | 2 | 2008 | 42 | 0.140 |
Why?
|
| Antilymphocyte Serum | 1 | 2017 | 43 | 0.130 |
Why?
|
| Hepatitis C | 1 | 2021 | 380 | 0.130 |
Why?
|
| Immunosuppressive Agents | 2 | 2017 | 649 | 0.130 |
Why?
|
| Veterans Health | 1 | 2018 | 171 | 0.130 |
Why?
|
| Acetylcysteine | 2 | 2008 | 79 | 0.130 |
Why?
|
| Hepatitis C, Chronic | 1 | 2021 | 363 | 0.130 |
Why?
|
| Female | 15 | 2021 | 68275 | 0.130 |
Why?
|
| Transplant Recipients | 1 | 2018 | 230 | 0.130 |
Why?
|
| Ileostomy | 1 | 2016 | 31 | 0.130 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 6663 | 0.120 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 658 | 0.110 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 259 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2018 | 4953 | 0.110 |
Why?
|
| Proton Pump Inhibitors | 1 | 2016 | 273 | 0.100 |
Why?
|
| Pandemics | 1 | 2021 | 1134 | 0.100 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2013 | 6 | 0.100 |
Why?
|
| Hygiene | 1 | 2012 | 23 | 0.100 |
Why?
|
| Hospitals, Veterans | 2 | 2021 | 341 | 0.090 |
Why?
|
| Blood-Brain Barrier | 1 | 2013 | 139 | 0.090 |
Why?
|
| Registries | 1 | 2018 | 1532 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 873 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 622 | 0.080 |
Why?
|
| Embolization, Therapeutic | 1 | 2013 | 221 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 734 | 0.080 |
Why?
|
| Staphylococcus epidermidis | 2 | 2007 | 39 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2016 | 5113 | 0.080 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2008 | 73 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 1136 | 0.080 |
Why?
|
| Time Factors | 1 | 2018 | 6126 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2017 | 16985 | 0.070 |
Why?
|
| Young Adult | 2 | 2018 | 9655 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1859 | 0.070 |
Why?
|
| Comorbidity | 2 | 2017 | 1559 | 0.070 |
Why?
|
| Equipment and Supplies | 1 | 2007 | 27 | 0.070 |
Why?
|
| Gram-Positive Bacteria | 1 | 2007 | 44 | 0.060 |
Why?
|
| Gram-Negative Bacteria | 1 | 2007 | 70 | 0.060 |
Why?
|
| Staphylococcus aureus | 2 | 2007 | 467 | 0.060 |
Why?
|
| Pyelitis | 1 | 2006 | 2 | 0.060 |
Why?
|
| Urinary Calculi | 1 | 2006 | 18 | 0.060 |
Why?
|
| Michigan | 1 | 2006 | 46 | 0.060 |
Why?
|
| Enterococcus | 1 | 2006 | 31 | 0.060 |
Why?
|
| Plasma Cells | 1 | 2006 | 53 | 0.060 |
Why?
|
| Embolism | 1 | 2006 | 43 | 0.060 |
Why?
|
| Granuloma | 1 | 2006 | 62 | 0.060 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2006 | 144 | 0.060 |
Why?
|
| Risk Factors | 4 | 2017 | 10545 | 0.060 |
Why?
|
| HIV Infections | 1 | 2017 | 1951 | 0.060 |
Why?
|
| Remission Induction | 1 | 2006 | 298 | 0.060 |
Why?
|
| Ureteral Obstruction | 1 | 2006 | 102 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 2039 | 0.060 |
Why?
|
| Pancreatic Diseases | 1 | 2005 | 42 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2016 | 3063 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2016 | 12537 | 0.050 |
Why?
|
| Outpatients | 1 | 2006 | 254 | 0.050 |
Why?
|
| Kidney Function Tests | 1 | 2005 | 133 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2005 | 214 | 0.050 |
Why?
|
| Escherichia coli Infections | 1 | 2006 | 184 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2006 | 1194 | 0.050 |
Why?
|
| Mitral Valve | 1 | 2006 | 250 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2012 | 6203 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2005 | 194 | 0.050 |
Why?
|
| Adolescent | 2 | 2018 | 19987 | 0.050 |
Why?
|
| Creatinine | 1 | 2005 | 381 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2006 | 553 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2006 | 1495 | 0.050 |
Why?
|
| Recurrence | 1 | 2006 | 1406 | 0.050 |
Why?
|
| Logistic Models | 2 | 2016 | 1779 | 0.050 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2006 | 428 | 0.050 |
Why?
|
| Opportunistic Infections | 1 | 2002 | 74 | 0.040 |
Why?
|
| Cyclosporine | 1 | 2002 | 126 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1597 | 0.040 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 556 | 0.040 |
Why?
|
| Length of Stay | 1 | 2007 | 1375 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2006 | 1047 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2005 | 629 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2005 | 481 | 0.040 |
Why?
|
| Allografts | 1 | 2021 | 189 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2021 | 263 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2005 | 1654 | 0.040 |
Why?
|
| Texas | 1 | 2007 | 3545 | 0.040 |
Why?
|
| Prevalence | 1 | 2005 | 2591 | 0.040 |
Why?
|
| Health Facilities | 1 | 2018 | 67 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2021 | 486 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2005 | 824 | 0.030 |
Why?
|
| Causality | 1 | 2017 | 89 | 0.030 |
Why?
|
| Bone Density Conservation Agents | 1 | 2017 | 57 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 2969 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2018 | 382 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 757 | 0.030 |
Why?
|
| Propensity Score | 1 | 2016 | 249 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2005 | 3583 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2005 | 1350 | 0.030 |
Why?
|
| Anti-HIV Agents | 1 | 2017 | 345 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 1207 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1374 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 1363 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2016 | 413 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 665 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2016 | 1193 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3311 | 0.020 |
Why?
|
| Incidence | 1 | 2017 | 3247 | 0.020 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2008 | 87 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2007 | 270 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 2007 | 140 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2006 | 639 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2008 | 1398 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2007 | 380 | 0.010 |
Why?
|
| Bacteria | 1 | 2007 | 502 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2002 | 301 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2002 | 759 | 0.010 |
Why?
|